சிறப்பு பார்மா நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
PM360 Magazine Announces Winners of 2021 Trailblazer Awards
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
PM360 Magazine Announces Winners of 2021 Trailblazer Awards
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Investegate |PAION AG Announcements | PAION AG: PAION AG ANNOUNCES INITIATION OF PIVOTAL STUDY OF REMIMAZOLAM (BYFAVO(R)) IN PEDIATRIC PROCEDURAL SEDATION
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Investegate |PAION AG Announcements | PAION AG: PAION LAUNCHES GIAPREZA(R) (ANGIOTENSIN II) FOR THE TREATMENT OF REFRACTORY HYPOTENSION IN ADULTS WITH SEPTIC OR OTHER DISTRIBUTIVE SHOCK IN GERMANY
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM
DGAP-News: PAION AG / Key word(s): Market launch
07.04.2021 / 09:00
PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO
TM (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM
Aachen (Germany), 07 April 2021 - The Specialty Pharma Company PAION AG (PA8; ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard) today announces that Hana Pharm, remimazolam licensee for South Korea, informed PAION about the launch of Byfavo
TM (remimazolam) for the use in general anesthesia in South Korea.
Remimazolam was approved in South Korea for general anesthesia in January 2021 and will be marketed under the brand name Byfavo